Abstract
BackgroundMycophenolate mofetil (MMF) has been shown to be a good therapeutic option in systemic lupus erythematosus (SLE), particularly lupus nephritis (LN). There is, however, evidence of variation in the response....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have